Literature DB >> 12175641

Rofecoxib-induced cholestatic hepatitis: treatment with molecular adsorbent recycling system (MARS).

Dominik Huster, Christian Schubert, Frieder Berr, Joachim Mössner, Karel Caca.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12175641     DOI： 10.1016/s0168-8278(02)00177-0

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  4 in total

1.  Cholestatic hepatitis in association with celecoxib. Classification of drug associated liver dysfunction is questionable.

Authors:  Faiyaz Mohammed; Alastair D Smith
Journal:  BMJ       Date:  2002-07-27

2.  Acute cholestatic hepatitis associated with long-term use of rofecoxib.

Authors:  Georgios I Papachristou; Anthony J Demetris; Mordechai Rabinovitz
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

Review 3.  Non-steroidal anti-inflammatory drugs: What is the actual risk of liver damage?

Authors:  Fernando Bessone
Journal:  World J Gastroenterol       Date:  2010-12-07       Impact factor: 5.742

4.  Rofecoxib-induced hepatotoxicity: a forgotten complication of the coxibs.

Authors:  Brian Yan; Yvette Leung; Stefan J Urbanski; Robert P Myers
Journal:  Can J Gastroenterol       Date:  2006-05       Impact factor: 3.522
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.